Navigation Links
Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
Date:4/6/2011

Administration ("FDA"); the outcome of further statistical analyses of the clinical data generated during the PREGNANT Study by the FDA; success in obtaining timely approval of PROCHIEVE in the new preterm birth indication by the FDA; the impact of competitive products and pricing; the timing and level of success of a future product launch; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to manufacturing facilities, products and/or businesses; changes in the laws and regulations, including Medicaid; competitive economic and regulatory factors in the pharmaceutical and healthcare industry; the ability to obtain and enforce patents and other intellectual property rights; general economic conditions; and other risks and uncertainties that may be detailed, from time-to-time, in Columbia's and Watson's reports filed with the SEC, including, but not limited to, their respective Annual Reports on Form 10-K for the year ended December 31, 2010. Neither Columbia nor Watson undertake any responsibility to revise or update any forward-looking statements contained herein, except as expressly required by law.

PROCHIEVE® and CRINONE® are registered trademarks of Watson Pharmaceuticals, Inc.

ContactsFor Columbia Laboratories, Inc.

For Watson Pharmaceuticals, Inc. Investors

InvestorsLawrence A. Gyenes

Patty EisenhaurSVP, Chief Financial Officer & Treasurer

VP, Investor Relations and Corp. Comm. Columbia Laboratories, Inc.

(973) 355-8141(973) 486-8860--or--

MediaSeth Lewis

Charlie MayrVP, The Trout Group LLC

SVP, Corporate Affairs(646) 378-2952

(973) 355-8483MediaAmy RaskopfPresident, Raskopf Communications, LLC(917) 673-5775Editors Note:A press conference sponsored by the Detroit Medical Center (DMC) and Wayne
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.; Columbia Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
2. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
3. Watson Confirms Columbia Laboratories Filing of Definitive Proxy Relating to Watsons Acquisition of U.S. Rights to CRINONE® Progesterone Gel Product Line
4. Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets
5. Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares of Columbia Laboratories
6. HealthWarehouse.com Partners with Columbia Medical Associates to Bring Affordable Healthcare to Washington State
7. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
8. Columbia Laboratories to Discuss Fourth Quarter and Year End 2010 Financial Results on March 10, 2011, Conference Call
9. Sanofi-aventis Enters Into Research Collaboration With Columbia University to Develop New Diabetes Treatments
10. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
11. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Bridgewater, New Jersey location received ... Administration (FDA) relating to an inspection in June 2014 ... injectable, which was divested to Galderma S.A. in July ... contract manufacturers (rather than Valeant,s own internal manufacturing) with ...
(Date:9/30/2014)... -- The Eastern European medical device industry is in ... as new medical-device manufacturers are constantly trying to penetrate ... to reduce the cost incurred for placing their products ... effective means to achieve this target. This research service ... and provides profiles of key distributors in ...
(Date:9/30/2014)... , Sept. 30, 2014   Decision ... patient-level claims data, anemic chronic kidney disease non-dialysis ... erythropoiesis-stimulating agent (ESA) medication. In addition, one-year persistency ... Other key findings from the ... An Analysis of Erythropoiesis Stimulating Agents in Late ...
Breaking Medicine Technology:Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3
... On Friday, April 20, 2012, at 8:30 a.m. Eastern/2:30 ... Inc.,s (CTI) (NASDAQ and MTA: CTIC) management team will ... first quarter achievements and financial results. ... Central European/5:30 a.m. Pacific Time 1-800-762-8779 (US Participants) ...
... 2012  Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... version of FORTAMET® (metformin hydrochloride extended-release tablets) as part ... the product today. FORTAMET® is indicated as an adjunct ... patients 17 years of age or older. ...
Cached Medicine Technology:Watson Launches Generic FORTAMET(R) 2
(Date:9/30/2014)... some stickleback fish fathers can have long-term effects on ... dads cause their offspring to behave in a way ... changes are accompanied by changes in gene expression, the ... the Proceedings of the Royal Society B: Biological ... moms are very important for their offspring," said ...
(Date:9/30/2014)... Asheville, North Carolina (PRWEB) September 30, 2014 ... cloud readiness and IT Infrastructure analytics across data ... announced it has achieved an important milestone of ... problems and plan for important projects such as ... workload migrations. , The strong customer engagement ...
(Date:9/30/2014)... 2014 Speaking on this occasion, ... ‘Nursing Conference’ as a remarkable event, which brings together ... and clinical research and diagnostic companies, leading universities and ... perfect platform to share experience, foster collaborations across industry ... Nursing Conference is a forum to explore issues of ...
(Date:9/30/2014)... 2014 MyMobileUni seeks to partner globally ... have similar shared vision to transform individuals and empower ... (MMU):, , to impact ... all ages , to have focused channels ... to promote equal access to education and ...
(Date:9/30/2014)... with bowel cancer for a genetic condition would cut ... new research has found. , In a major study, ... and researchers from the University of Exeter,s Medical School ... for a genetic condition known as Lynch Syndrome. ... by changes in genes which check the spelling in ...
Breaking Medicine News(10 mins):Health News:In stickleback fish, dads influence offspring behavior and gene expression 2Health News:In stickleback fish, dads influence offspring behavior and gene expression 3Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 2Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 3Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 2Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 3Health News:MyMobileUniversity Call to Public and Private Organisations, NGOs’ and Individuals: Catalyze Positive Social Change, Let’s Transform Individuals and Empower Communities 2Health News:MyMobileUniversity Call to Public and Private Organisations, NGOs’ and Individuals: Catalyze Positive Social Change, Let’s Transform Individuals and Empower Communities 3Health News:Genetic test would help 'cut bowel cancer spread' 2Health News:Genetic test would help 'cut bowel cancer spread' 3
... one species of bacteria could be more persistent and ... other, encouraging it to bolster its defenses. Interrupting ... these infections. Researchers from Wake Forest University Baptist ... , the online open-access journal of the American Society ...
... ... Boise, Idaho acupuncture clinic, recently relocated to a larger office and more convenient ... acupuncture clinic is now located in very close proximity to one of the ... licensed acupuncturists and 2 massage therapists working collaboratively to help patients get and ...
... 2010 Elsevier, the world-leading publisher of scientific, technical ... Society of Geriatric Oncology (SIOG) announced today the launch ... www.geriatriconcology.net ). The journal is focused on advancing ... of older adults with cancer. It covers all ...
... ... health care organizations better comply with OASIS-C and improve staff performance and patient outcomes ... new and updated patient and caregiver teaching resources. , ... (PRWEB) July 6, 2010 -- Pritchett & Hull ...
... Site ... ... Surgery (ASAPS) is proud to introduce Project Beauty , a new consumer website, that ... one the leading medical authorities in Beauty - The American Society for Aesthetic Plastic Surgery., , ...
... ... Though Advanced Software Testing Services and Methodologies , ... Naples, FL (PRWEB) July 6, 2010 -- QualEDIx, a ... ICD-10 software testing services network is pleased to announce that healthcare industry veteran, Larry ...
Cached Medicine News:Health News:Bacterial communication encourages chronic, resistant ear infections 2Health News:Boise Acupuncture Clinic Grows into Larger Office 2Health News:Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology 2Health News:Aesthetic Society Launches Project Beauty, ,NEW Consumer Website Covering All Things Beauty, 2Health News:Aesthetic Society Launches Project Beauty, ,NEW Consumer Website Covering All Things Beauty, 3Health News:Larry Watkins Joins QualEDIx as Executive Vice President, Healthcare Strategy and Business Development 2Health News:Larry Watkins Joins QualEDIx as Executive Vice President, Healthcare Strategy and Business Development 3
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal ... 20-200 ... 1.0~2.0 Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: